Search Bar & Filters
Found 5 Actively Recruiting clinical trials
Actively Recruiting
Healthy Volunteer
Study of Chemotherapy Effects on Thinking and Brain Changes in Women 60 and Older With Breast Cancer
Researchers are evaluating how chemotherapy affects thinking and brain function in older adults with breast cancer. The study aims to identify chemo-brain, which refers to cognitive changes caused by chemotherapy, and to find people most at risk for these effects. It focuses on assessing thinking abilities and brain images before and after chemotherapy treatment. Participants include three groups breast cancer patients receiving chemotherapy, breast cancer patients not receiving chemotherapy, and healthy volunteers. All participants undergo cognitive and functional assessments along with brain imaging using MRI or PET scans at various points before and after treatment or enrollment. During the study, participants complete memory and thinking tests and undergo brain scans before treatment, immediately after chemotherapy, and six months later. Researchers measure changes in cognitive performance and brain markers like amyloid and tau accumulation. The study monitors participants for cognitive effects related to chemotherapy and continues until January 2028.
Actively Recruiting
Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.
Actively Recruiting
This research aims to improve outcomes for older patients undergoing colorectal surgery by testing a care transition intervention after hospital discharge. The study focuses on reducing hospital readmissions within 30 days, which often happen due to medication errors, surgical complications, or worsening chronic conditions. It evaluates a combined approach using the OSCAR co-management model and a care transition intervention CTI tailored for older adults. The intervention involves a surgery nurse coach providing support to patients and their families as they transition from hospital to home. The CTI includes in-person visits and phone calls over four weeks, addressing medication management, personal health records, timely follow-up care, and recognizing warning signs of health decline. This hybrid study combines geriatric surgical care with transition coaching to meet the unique needs of older colorectal surgery patients. Participants will have regular interactions with the nurse coach and complete assessments related to readmission or death within 30 days after discharge. The study also measures patient satisfaction, postoperative complications, and implementation factors such as reach, fidelity, and adoption over 12 months. The total participation involves monitoring the transition process and outcomes to assess the feasibility and effectiveness of the OSCAR-S care transition model.
Actively Recruiting
Researchers are evaluating a personalized blood clot prevention plan compared to standard treatment in adults with peripheral artery disease PAD who have undergone procedures to restore blood flow to their legs. This study aims to see if the personalized plan reduces blood clots, amputations, repeat procedures, bleeding, and death over one year. The personalized approach uses a blood test to tailor blood clot prevention medications. Participants are randomly assigned to either the personalized TARGET plan or standard treatment. The TARGET plan uses serial Thromboelastography with Platelet Mapping TEG-PM blood tests at 1 week and at 1, 3, 6, 9, and 12 months after the procedure to adjust antiplatelet medications and maintain platelet inhibition within a therapeutic range. The standard treatment group receives usual care with no medication changes based on TEG-PM results. Throughout the study, blood tests are collected regularly to monitor coagulation and platelet function. Researchers measure the incidence of arterial thrombosis in the treated limb and track rates of amputation-free survival, mortality, repeat interventions, and bleeding events up to 12 months after revascularization. Medication adjustments are made in the TARGET group based on test results, and all participants are followed for one year to assess outcomes and safety.
Actively Recruiting
This research aims to evaluate if adding an artificial intelligence AI algorithm to analyze fundus photographs, along with measuring eye pressure and visual field testing, can improve glaucoma screening. The study focuses on people with diabetes since they have a higher risk of developing glaucoma. Integrating glaucoma screening into existing diabetic eye disease DED programs may help detect glaucoma earlier and prevent vision loss. Participants are divided into two groups. One group will have their fundus photos analyzed by AI for glaucoma signs, along with eye pressure measurement, and if needed, virtual reality visual field testing. The other group will receive routine diabetic eye disease screening, including AI analysis for diabetic retinopathy only. This study uses devices like the Icare tonometer and Olleyes virtual reality system to assess eye health. During the study, participants will have fundus images taken as part of diabetic eye screening and eye pressure measured. If glaucoma is suspected, additional side vision testing will be conducted using a headset. Researchers will monitor glaucoma detection one year after screening and assess cost-effectiveness, participant satisfaction, and knowledge about glaucoma on the day of screening. The study is expected to run until September 2030.